What Does FDA Clearance Cover for a PRP Kit?
What does FDA clearance cover for a PRP kit, and what claims are not permitted?
Clearance is a verdict on a piece of equipment, not on a treatment. When you read that a kit is cleared, what you're being told is that the tubes, the spin and the separation step reliably produce concentrated platelets from a small draw of the patient's own blood, and nothing more. That gap between what was actually reviewed and what people assume was reviewed is where almost every claim problem on a clinic website starts.
- Pathway: Class II devices reach the market through 510(k) premarket notification, not approval.
- What's reviewed: Substantial equivalence to a predicate device, not clinical proof of any outcome.
- Indication for use: Rapid preparation of platelet-rich plasma at the point of care.
- Out of bounds: "FDA approved," guarantees, cure language, and untested superiority claims.
A platelet concentration system is 510(k) cleared as a Class II device for preparing platelet-rich plasma from a small sample of the patient's own blood, and no clearance covers scalp injection for hair loss, which makes that use off-label.
How do FDA clearance, approval, and registration differ, and which one applies to a platelet concentration system?
Three different things happen at the agency, and everyday marketing collapses all of them into one word. Registration is paperwork, clearance is a comparison against a device already on the market, and approval is the only one where anybody looks at whether a treatment works. Knowing which one you're standing on tells you exactly how much you're allowed to say.
| Criteria | Registration and listing | 510(k) clearance | Premarket approval |
|---|---|---|---|
| What happens | Fee paid, entry in a public database | Comparative review against a predicate device | Full evidence review |
| Evidence submitted | None | Bench testing, biocompatibility, sterilization, platelet yield | Clinical trials |
| Says the treatment works | No | No | Yes |
| Applies to PRP kits | Yes | Yes, as Class II | No |
Platelet concentration systems are Class II devices that reach the market through the 510(k) route, so the accurate phrase is 510(k) cleared, and calling one FDA approved describes a premarket approval review that never took place.
What indication for use is actually written on the clearance for most platelet concentration systems?
The indication written on a clearance is shorter and blunter than the sales sheet that quotes it. The family wording running through this device category describes safe and rapid preparation of platelet-rich plasma from a small sample of blood at the point of care, and several older clearances still tack on mixing that plasma with bone graft material at an orthopedic surgical site. Read the indications for use page of the clearance letter, not the brochure.
- Cleared wording: Rapid preparation of platelet-rich plasma from a small blood sample at the point of care.
- Orthopedic tail: Older clearances add mixing with bone graft material at a surgical site.
- Varies by maker: Each submission carries its own text under its own product code.
- Never present: Hair density, follicle survival, tendon healing, or pain reduction.
The cleared indication for most platelet concentration systems describes only the safe and rapid preparation of platelet-rich plasma from a small sample of blood at the point of care, with no clinical outcome of any kind written into it.
Which parts of a PRP system are covered by the clearance and which are not?
A clearance covers one validated system, not a category of activity, and that boundary is easier to step over than most clinics realize. The tubes, the gel or filter and the spin program were tested together, so swapping in a component for a cheaper equivalent quietly puts you outside the file the clearance rests on. Whatever you change, you now own.
| Element | Inside the cleared system | Outside it |
|---|---|---|
| Disposables | Tubes, gel or filter and closures, validated together | Another company's tubes in the same run |
| Hardware | The centrifuge and spin program the submission tested | A general lab instrument swapped in |
| Additives | The citrate anticoagulant supplied with the kit | Activators introduced to the plasma afterward |
| Protocol | The spin times the manufacturer validated | Longer spins chasing a higher concentration |
The clearance covers the specific disposables, centrifuge and spin protocol the manufacturer validated as one system, while the plasma itself is a blood product expressly excluded from the human cells and tissue framework and handled through the same-day, same-patient, closed-system workflow rather than through the kit's clearance.
Why does using platelet-rich plasma for hair restoration count as off-label?
Off-label describes the paperwork, not the medicine. No platelet concentration system carries a cleared indication for androgenetic alopecia, so every scalp injection performed in the country is off-label by definition, including the ones done well by experienced physicians. That's lawful, and it puts the justification on you rather than on a regulator.
Hair restoration with platelet-rich plasma is off-label because no platelet concentration system holds a cleared indication for androgenetic alopecia, and while a licensed physician may lawfully make that call, the evidence behind it lives in the published literature rather than in any clearance file.
Which advertising claims about platelet-rich plasma draw regulatory enforcement?
Enforcement here isn't random. It clusters around four claim patterns that turn up again and again, and clinics walk into them by copying wording that looks normal because everyone else is using it. If your page does any of these four things, you're the easy case.
- Status claims: "FDA approved," "government approved," or "approved for hair loss" on a cleared kit.
- Unsupported outcomes: Health claims published with no competent and reliable scientific evidence behind them.
- Absolutes: Guarantees, "permanent," "cure," "stops hair loss," "works for everyone."
- Social proof: Testimonials or photos showing the best case rather than typical results.
Enforcement concentrates on four claim types, misstated regulatory status, unsubstantiated outcome claims, absolute promises, and testimonials or before-and-after imagery presenting best-case rather than typical results, with the FDA taking device labeling and promotion and the Federal Trade Commission taking advertising more broadly.
Where does the line sit between a manufacturer's promotion and a physician's practice of medicine?
Two rulebooks meet at the treatment room door, and which one applies depends on who's doing the talking. A company can't market its device for a use it never cleared. You can treat as your judgement directs, but the moment you lift the company's marketing copy onto your own site, those claims are yours.
| Question | Manufacturer | Clinic |
|---|---|---|
| Who oversees the claims | The FDA, through labeling and promotion rules | State boards, state consumer law, and the FTC |
| What's restricted | Marketing the device beyond its cleared indication | Advertising that isn't truthful and substantiated |
| What's allowed | Reprints, unsolicited requests, real scientific exchange | Describing the treatment, the evidence, and its limits |
| Where it goes wrong | Orchestrated demand for the uncleared use | Republishing the maker's claims under your own name |
A manufacturer may not promote a device beyond its cleared indication, while a clinic answers to state medical boards, state consumer protection law and the FTC for whether its advertising is truthful, substantiated and not misleading, so copying a manufacturer's claims onto a clinic page moves the liability to the clinic without moving any protection with it.
How should a clinic describe a cleared device without overstating what clearance means?
Start from the sentence you could say to a regulator's face and build outward from there. Everything else on the page is either consistent with that sentence or it's a problem waiting to be found.
- Write the defensible sentence: Name the device as a 510(k) cleared Class II system for preparing platelet-rich plasma from the patient's own blood, and name the hair use as off-label.
- Fix the verbs: "Describes," "prepares," "concentrates" and "is intended for" are factual. "Proven," "guaranteed," "approved for," "cures" and "restores" are not.
- Keep response language conditional: Studies report a range of results and a share of patients who respond poorly, and saying so costs you far less than you think.
- Place the disclosure where it's read: Beside the treatment description, not in a site-wide footer that no regulator has ever accepted as a fix for a misleading headline.
- Give claim review an owner: One named person signs off, every outcome statement traces to a source, and the clearance number and indication text stay on file.
The defensible description is that the system is a 510(k) cleared Class II device for preparing platelet-rich plasma from a small sample of the patient's own blood and that its use for hair restoration is an off-label application chosen by the treating clinician, with that disclosure placed beside the treatment description rather than in a footer.
What penalties follow from promoting a device beyond its cleared indication?
Consequences arrive in tiers, and the cheap ones come first. A warning letter costs you a rewrite and a response inside about fifteen working days; ignoring it costs a great deal more. The tier nobody settles is the last one.
Promoting a device beyond its cleared indication usually opens with a warning letter requiring a written response within about fifteen working days and escalates to injunctions, seizure, consent decrees and misbranding prosecution, running alongside consumer protection remedies including refunds and state medical board action against the license, and the published record outlasts every correction.
